Atai Life Sciences Nv share price logo

Atai Life Sciences Nv Share Price

NASDAQ: ATAI

Small Cap

$4.62

-0.03

(-0.65%)

as on

Atai Life Sciences Nv Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $4.58
    $4.78
    downward going graph

    0.87%

    Downside

    3.46%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.03
    $5.34
    downward going graph

    77.71%

    Downside

    15.58%

    Upside

    downward going graph

Atai Life Sciences Nv share price movements today

Previous Close
$4.65
Open
$4.64
Volume
2.9M
Day's Low - High
$4.58 - $4.78
52 Week Low - High
$1.03 - $5.34

Atai Life Sciences Nv Historical Returns

1 Month Return
+ 19.85 %
3 Month Return
+ 109.46 %
1 Year Return
+ 263.28 %
3 Year Return
+ 20.47 %
5 Year Return
0 %

Atai Life Sciences Nv Stock Fundamentals & Key Indicators

Check Atai Life Sciences Nv market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$996.7M

EPS (TTM)

-0.5033

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.97%

PE Ratio (TTM)

-3.76

Industry PE ratio

-3.9281873111782475

P/B Ratio

0

PEG Ratio

0

EBITDA

-94.8M

Revenue (TTM)

2.3M

Profit Margin

0.00%

Return On Equity TTM

2047201600.00%

Atai Life Sciences Nv Stock Valuation

Track how Atai Life Sciences Nv P/E has moved over time to understand its valuation trends.

Atai Life Sciences Nv in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 17, 2025

Industry (-3.93x)

September 17, 2025

Today (-3.76x)

September 17, 2025

Highest (0.00x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: -3.76x

Atai Life Sciences Nv vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Atai Life Sciences Nv with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Atai Life Sciences Nv image
Atai Life Sciences Nv
BUY$996.7MNA-3.760.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$60.5B252.04%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$39.0BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$100.3B44.17%27.8531.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Atai Life Sciences Nv Stock including INR - Dollar returns

The Atai Life Sciences Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Atai Life Sciences Nv investment value today

Current value as on today

₹3,65,536

Returns

₹2,65,536

(+265.54%)

Returns from Atai Life Sciences Nv Stock

₹2,60,938 (+260.94%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Atai Life Sciences Nv Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Atai Life Sciences Nv. Average target price of $11.29

Atai Life Sciences Nv Share Price Target

Get share price movements and forecasts by analysts on Atai Life Sciences Nv.

What analysts predicted

59.08%UPSIDE

Target Price

$11.29

Current Price

$4.62

Analyzed by

13 Analysts

Target

$11.29

Atai Life Sciences Nv target price $11.29, a slight upside of 59.08% compared to current price of $4.62. According to 13 analysts rating.

Atai Life Sciences Nv Stock's Interest Amongst Investors

Search interest for Atai Life Sciences Nv Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-14% versus previous 30 day period

Atai Life Sciences Nv Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
0
0
0
-
0
0
0
1
0
Gross Profit
0
0
0
0
0
0
0
0
1
0
Operating Income
-32
-31
-26
-33
-23
-25
-22
-30
-20
-25
EBITDA
-32
-30
-26
-17
-24
-56
-25
-38
-25
-27
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-33
-31
43
-18
-25
-57
-26
-39
-26
-27
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-33
-33
44
-18
-26
-57
-26
-38
-26
-27
Net Profit Margin
-90056.76%
-19210.47%
50855.17%
-101622.22%
0.00%
-20993.41%
-65715.00%
779160.00%
-1699.74%
-3856.61%

Atai Life Sciences Nv Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
19
20
0
0
0
Gross Profit
0
0
20
0
0
0
Operating Income
1
-104
-135
-144
-125
-102
EBITDA
-17
-92
-120
-135
-36
-145
Interest Expense
15
71
66
0
2
3
Depreciation
0
0
0
0
0
0
Income Before Tax
-17
-101
-136
-135
-39
-148
Income Tax Expense
0
0
-3
6
1
0
Net Income
-17
-102
-132
-141
-40
-149
Net Profit Margin
0.00%
-513.67%
-650.82%
-60691.42%
-12810.19%
-48463.96%

Atai Life Sciences Nv Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-33
43
-18
-26
-57
-26
-38
-26
-27
Operating Cash Flow
-22
-18
-21
-22
-16
-19
-24
-17
-14
Investing Cash Flow
-22
-46
0
11
16
24
6
-11
9
Financing Cash Flow
0
0
-8
-
0
4
0
59
7
Change in Cash
-44
-64
-31
-21
0
10
-17
30
3

Atai Life Sciences Nv Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-178
-174
-157
-40
-150
Operating Cash Flow
-20
-63
-104
-84
-82
Investing Cash Flow
-28
-81
-86
-53
59
Financing Cash Flow
113
409
20
-8
5
Change in Cash
67
265
-171
-145
-17

Global Institutional Holdings in Atai Life Sciences Nv

Funds
Holdings
UBS Group AG
2.61%
Morgan Stanley - Brokerage Accounts
1.55%
Pale Fire Capital SE
1.22%
Davidson Kempner Capital Management LP
0.67%
Millennium Management LLC
0.54%
See all

Insights on Atai Life Sciences Nv

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ATAI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ATAI stock has moved up by 99.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 96.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -26.43M → -27.72M (in $), with an average decrease of 4.9% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.55M → 719.0K (in $), with an average decrease of 53.8% per quarter

About Atai Life Sciences Nv

who we are: atai is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. our mission: we are committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space. our approach: by pooling expertise, best practices, and resources across our entire portfolio, we mitigate risk and responsibly accelerate the development of impactful and evidence-based treatments.
OrganisationAtai Life Sciences Nv
HeadquartersWallstraße 16, Berlin, Germany, 10179
IndustryCommercial Services
CEODr. Srinivas G. Rao M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Atai Life Sciences Nv

Name

Title

Dr. Glenn Short Ph.D.

Chief Scientific Officer

Mr. Ryan Barrett J.D.

General Counsel & Corporate Secretary

Dr. Kevin Craig M.D.

Chief Medical Officer

Mr. Christian Angermayer

Co-Founder & Chairman of the Supervisory Board

Dr. Srinivas G. Rao M.D., Ph.D.

Co-Founder, CEO & Executive Director

Ms. Anne Johnson

Chief Financial Officer

Dr. Gerd G. Kochendoerfer Ph.D.

Chief Operating Officer

FAQs

What is Atai Life Sciences Nv share price today?

Atai Life Sciences Nv share price today is $4.62 as on at the close of the market. Atai Life Sciences Nv share today touched a day high of $4.78 and a low of $4.58.

What is the 52 week high and 52 week low for Atai Life Sciences Nv share?

Atai Life Sciences Nv share touched a 52 week high of $5.34 on and a 52 week low of $1.03 on . Atai Life Sciences Nv stock price today i.e. is closed at $4.62,which is 13.48% down from its 52 week high and 348.54% up from its 52 week low.

What is Atai Life Sciences Nv's market capitalisation today?

Atai Life Sciences Nv market capitalisation is $0.00T as on .

How to invest in Atai Life Sciences Nv Stock (ATAI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Atai Life Sciences Nv on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atai Life Sciences Nv Shares that will get you 0.3247 shares as per Atai Life Sciences Nv share price of $4.62 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Atai Life Sciences Nv Stock (ATAI) from India?

Indian investors can start investing in Atai Life Sciences Nv (ATAI) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Atai Life Sciences Nv stock (as per the Rupee-Dollar exchange rate as on ). Based on Atai Life Sciences Nv share’s latest price of $4.62 as on September 18, 2025 at 1:29 am IST, you will get 2.1645 shares of Atai Life Sciences Nv. Learn more about fractional shares .